Oncolytics Biotech Competes Safety Phase Enrollment for GOBLET Trial's Pancreatic Cancer Cohort

MT NewswiresDec 3 07:34 ET

Oncolytics Biotech Brief: Reporting Completion of Initial Safety Phase Enrollment for GOBLET Trial's New Pancreatic Cancer Cohort

MT NewswiresDec 3 07:01 ET

Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend

PR NewswireDec 2 10:18 ET

RBC Capital Maintains Oncolytics Biotech(ONCY.US) With Buy Rating, Cuts Target Price to $4.29

Moomoo NewsNov 14 07:31 ET · Ratings

Oncolytics Biotech Inc. (ONCY) Q3 2024 Earnings Call Transcript Summary

moomoo AINov 13 21:05 ET · Conference Call

Oncolytics Biotech Inc. (ONCY) Q3 2024 Earnings Call Transcript

Earnings Call TranscriptsNov 13 21:01 ET